PR Newswire SILVER SPRING, Md., Aug. 30, 2024 SILVER SPRING, Md., Aug. 30, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine ...
PR Newswire PROVIDENCE, R.I., Aug. 28, 2024 PROVIDENCE, R.I., Aug. 28, 2024 /PRNewswire/ -- As post-COVID-19 Conditions or "Long COVID" continues to challenge millions of Americans, a new study published in Annals of Family Medicine reveals ...
PR Newswire SEOUL, South Korea, Aug. 28, 2024 SEOUL, South Korea, Aug. 28, 2024 /PRNewswire/ -- Hyundai Bioscience Co., Ltd, currently pursuing Emergency Use Authorization (EUA) for its oral COVID-19 treatment, Xafty®, for mild-to-moderate ...
PR Newswire HOUSTON, Aug. 27, 2024 Dr. Chris Langan, a board-certified emergency room physician, urged Texans to be cautious as the US experiences an uptick in COVID-19 occurrences. HOUSTON, Aug. 27, 2024 /PRNewswire-PRWeb/ -- The US is ...
PR Newswire SILVER SPRING, Md., Aug. 22, 2024 SILVER SPRING, Md., Aug. 22, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 ...
PR Newswire SAN FRANCISCO, Aug. 20, 2024 And Finds Discrepancies in Reporting between News Media and FBI Data SAN FRANCISCO , Aug. 20, 2024 /PRNewswire/ -- The Asian American Foundation (TAAF) today released findings from its study Roots ...
PR Newswire WASHINGTON, Aug. 14, 2024 WASHINGTON, Aug. 14, 2024 /PRNewswire/ -- The FLCCC Alliance categorically disagrees with the recent decision by the American Board of Internal Medicine (ABIM) regarding the revocation of board ...
HUNTINGTON, N.Y. , June 24, 2024 /PRNewswire/ -- Sen-Jam Pharmaceutical is pleased to announce the successful completion of participant enrollment for the clinical trial of its innovative therapeutic, SJP-002C in partnership with ...
HUNTINGTON, N.Y. , May 22, 2024 /PRNewswire/ -- Sen-Jam Pharmaceutical, a leading innovator in the development of therapeutics for age-related diseases, is pleased to announce the upcoming completion of the clinical trial for its ...
Zimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program. MINNEAPOLIS, Minn. , April 29, 2024 /PRNewswire-PRWeb/ -- ...
Long COVID is draining the economy by billions every year, as workers battle persistent symptoms and face challenges returning to their jobs, reports a new study led by UCL researchers. ...
A new clinical study reveals that an inhibitor of Fas ligand (FasL), also known as CD95 ligand (CD95L), could be the latest game-changing treatment for COVID-19....
Researchers are utilizing AI to detect long COVID symptoms, monitor their progression, and rule out other potential causes. This innovative approach suggests that a substantial 22.8% of the population may be affected by long-term COVID-19 ...
A study led by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) explores public trust in COVID-19 vaccine science and its influence on vaccine acceptance ...
A new study reveals a concerning link between COVID-19 and dyslipidemia. The pandemic led to a 29% increase in dyslipidemia risk, especially among seniors and people with type 2 diabetes. This condition, characterized by abnormal blood lipid levels, significantly elevates the risk of heart attack and stroke. ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers